申请人:Allergan, Inc.
公开号:US20160096832A1
公开(公告)日:2016-04-07
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及有机分子,能够调节酪氨酸激酶信号传导,以调节、调控和/或抑制异常细胞增殖。